The potential function of microRNA in chordomas

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Chordomas are rare, chemoresistant tumors lacking established treatments.
• MicroRNAs (miRNAs) are crucial regulators of gene networks and cellular pathways.
• Understanding miRNA dysregulation in chordomas is key to elucidating tumor initiation and progression.

Purpose of the Study:

• To evaluate the effects of dysregulated miRNAs on chordoma cell lines.
• To identify potential molecular mechanisms underlying chordoma development.
• To explore novel therapeutic targets for chordoma.

Main Methods:

• Transient transfection of specific miRNA mimics (miR-31, anti-miR-140-3p, anti-miR148a, miR-222) into chordoma cell lines.
• Assessment of cell viability (MTS assay), apoptosis, and cell cycle progression.
• Real-time polymerase chain reaction to analyze mRNA levels of miRNA targets and epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) markers.

Main Results:

• miR-31 significantly decreased cell viability and induced S-phase arrest in chordoma cell lines.
• Both miR-31 and anti-miR-148a promoted apoptosis across all tested cell lines.
• miR-222 levels correlated positively with EMT markers and negatively with MET markers.
• Identified targets include RDX, MET, DNMT1, DNMT3B, TRPS1, BIRC5, and KIT.

Conclusions:

• miR-31, miR-140-3p, miR-148a, and miR-222-3p show potential as key regulators of chordoma cell viability, apoptosis, and cell cycle.
• These miRNAs may play significant roles in chordoma initiation, differentiation, and progression.
• Further investigation into these miRNAs could lead to novel therapeutic strategies for chordoma.